Abstract
Background Both small-quantity (SQ) and medium-quantity (MQ) lipid-based nutrient supplements (LNS) have been used for prevention of child undernutrition. A meta-analysis of 14 trials of SQ-LNS vs no LNS showed effects on length-for-age (LAZ, +0.14 (95% confidence interval 0.11, 0.16)) and weight-for-length (WLZ, +0.08 (0.06, 0.10)) z-scores, as well as prevalence ratios (95% CI) for stunting (LAZ<-2, 0.88 (0.85, 0.91)) and wasting (WLZ < −2, (0.80, 0.93)). However, little is known about the effects of MQ-LNS on growth.
Objective We aimed to examine the effects of preventive MQ-LNS (∼250-499 kcal/d) provided at ∼6-23 mo of age on growth outcomes compared to no LNS or provision of SQ-LNS.
Methods We conducted a systematic review of studies of MQ-LNS for prevention, and categorized them as providing < 6 mo vs. > 6 mo of supplementation; for the latter category we conducted a meta-analysis, with main outcomes being change in WLZ and LAZ, and prevalence of wasting and stunting.
Results Three studies provided MQ-LNS for 3-5 mo (seasonal) for children 6-36 mo of age, and did not show consistent effects on growth outcomes. Eight studies provided MQ-LNS for 6-18 mo, generally starting at 6 mo of age; in the meta-analysis (max total n=13,673), MQ-LNS increased WLZ (+0.09 (0.05, 0.13)) and reduced wasting (0.89 (0.81, 0.97)), but had no effect on LAZ (+0.04 (−0.02, 0.11)) or stunting (0.97 (0.92, 1.02)) compared to no LNS. Two studies directly compared SQ-LNS and MQ-LNS and showed no significant differences in growth outcomes.
Conclusions The current evidence suggests that MQ-LNS offers no added benefits over SQ-LNS, although further studies directly comparing MQ-LNS vs. SQ-LNS would be useful. One possible explanation is incomplete consumption of the MQ-LNS ration and thus lower than desirable intake of certain nutrients.
Registry PROSPERO CRD42022382448: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022382448
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PROSPERO CRD42022382448
Clinical Protocols
Funding Statement
This study was funded by Bill & Melinda Gates Foundation OPP49817. The funder had no role in the design, implementation, analysis or interpretation of the data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data described in the manuscript are publicly available via referenced articles.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data described in the manuscript are publicly available via referenced articles and the aggregated data and code are available upon request.
Abbreviations
- GRADE
- Grading of Recommendations Assessment, Development and Evaluation
- HAZ
- height-for-age z-score
- IPD
- individual participant data
- IYCF
- infant and young child feeding
- LAZ
- length-for-age z-score
- LNS
- lipid-based nutrient supplements
- LQ-LNS
- large-quantity lipid-based nutrient supplements
- MAM
- moderate acute malnutrition
- MD
- mean difference
- MQ-LNS
- medium-quantity lipid-based nutrient supplements
- MUAC
- mid-upper arm circumference
- MUACZ
- mid-upper arm circumference-for-age z-score
- PD
- prevalence difference
- PR
- prevalence ratios
- RCT
- randomized controlled trial
- RNI
- recommended nutrient intake
- RUTF
- ready-to-use therapeutic food
- SAM
- severe acute malnutrition
- SBCC
- social and behavior change communication
- SMC
- seasonal malaria chemoprevention
- SQ-LNS
- small-quantity lipid based nutrient supplements
- UCT
- unconditional cash transfer
- WAZ
- weight-for-age z-score
- WFP
- World Food Programme
- WHZ
- weight-for-height z-score
- WLZ
- weight-for-length z-score
- WSB+
- wheat-soy blend plus Registry and registry number for systematic reviews or meta-analyses: Registered with PROSPERO as CRD42022382448 on December 18, 2022: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022382448.
